iRhythm Technologies (IRTC) Competitors $140.67 -0.54 (-0.38%) As of 02:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRTC vs. SOLV, SNN, PEN, STVN, GKOS, NARI, INSP, BLCO, TMDX, and SLNOShould you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), TransMedics Group (TMDX), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry. iRhythm Technologies vs. Solventum Smith & Nephew Penumbra Stevanato Group Glaukos Inari Medical Inspire Medical Systems Bausch + Lomb TransMedics Group Soleno Therapeutics iRhythm Technologies (NASDAQ:IRTC) and Solventum (NYSE:SOLV) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, community ranking, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Is IRTC or SOLV more profitable? Solventum has a net margin of 0.00% compared to iRhythm Technologies' net margin of -19.14%. Solventum's return on equity of 0.00% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets iRhythm Technologies-19.14% -118.83% -11.34% Solventum N/A N/A N/A Do analysts recommend IRTC or SOLV? iRhythm Technologies presently has a consensus target price of $128.55, indicating a potential downside of 8.97%. Solventum has a consensus target price of $80.29, indicating a potential upside of 7.52%. Given Solventum's higher probable upside, analysts clearly believe Solventum is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.91Solventum 1 Sell rating(s) 7 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.10 Does the MarketBeat Community prefer IRTC or SOLV? iRhythm Technologies received 411 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 66.19% of users gave iRhythm Technologies an outperform vote while only 7.41% of users gave Solventum an outperform vote. CompanyUnderperformOutperformiRhythm TechnologiesOutperform Votes41366.19% Underperform Votes21133.81% SolventumOutperform Votes27.41%Underperform Votes2592.59% Which has preferable earnings & valuation, IRTC or SOLV? Solventum has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRhythm Technologies$618.59M7.29-$123.41M-$3.14-44.97Solventum$8.31B1.55$373.71M$2.1634.57 Does the media favor IRTC or SOLV? In the previous week, Solventum had 12 more articles in the media than iRhythm Technologies. MarketBeat recorded 20 mentions for Solventum and 8 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.48 beat Solventum's score of 1.40 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solventum 15 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarySolventum beats iRhythm Technologies on 9 of the 15 factors compared between the two stocks. Get iRhythm Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRTC vs. The Competition Export to ExcelMetriciRhythm TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.51B$4.54B$5.43B$8.48BDividend YieldN/A43.65%5.22%4.11%P/E Ratio-38.7929.8726.7920.05Price / Sales7.2970.43395.67116.44Price / CashN/A51.0838.2534.62Price / Book20.616.346.864.61Net Income-$123.41M$67.64M$3.22B$248.19M7 Day Performance0.53%21.94%6.80%2.97%1 Month Performance43.17%26.54%13.69%16.58%1 Year Performance54.33%22.75%18.25%8.16% iRhythm Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRTCiRhythm Technologies1.3035 of 5 stars$140.67-0.4%$128.55-8.6%+52.5%$4.49B$618.59M-38.661,790Positive NewsSOLVSolventum2.043 of 5 stars$74.85+6.6%$79.00+5.5%+20.4%$12.95B$8.25B27.2222,000Positive NewsAnalyst UpgradeSNNSmith & Nephew2.2622 of 5 stars$28.43+0.3%$28.00-1.5%+12.9%$12.45B$5.81B13.1620,100News CoveragePositive NewsPENPenumbra4.7276 of 5 stars$296.98-0.1%$302.40+1.8%+39.5%$11.50B$1.24B873.473,900Positive NewsSTVNStevanato Group1.2589 of 5 stars€23.64-1.5%N/A+21.2%$7.16B$1.10B50.304,650GKOSGlaukos4.6725 of 5 stars$94.57+5.1%$134.67+42.4%-10.7%$5.40B$404.52M-32.95780News CoveragePositive NewsGap UpNARIInari Medical0.4726 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800News CoverageINSPInspire Medical Systems4.7097 of 5 stars$156.54+3.5%$211.91+35.4%-3.4%$4.62B$840.11M90.49760Positive NewsGap UpBLCOBausch + Lomb4.3042 of 5 stars$11.91+5.6%$15.50+30.2%-19.2%$4.21B$4.83B-13.0812,500Gap UpTMDXTransMedics Group1.4408 of 5 stars$118.73+6.5%$126.70+6.7%-10.0%$4.02B$488.23M126.31210Gap UpSLNOSoleno Therapeutics4.8601 of 5 stars$76.70-0.1%$106.78+39.2%+59.6%$3.87BN/A-23.1030News CoveragePositive News Related Companies and Tools Related Companies Solventum Alternatives Smith & Nephew Alternatives Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives Inari Medical Alternatives Inspire Medical Systems Alternatives Bausch + Lomb Alternatives TransMedics Group Alternatives Soleno Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRTC) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IRTC Stock Free IRTC Stock Alerts